Cryo-Cell International, Inc. (CCEL) Stock Forecast
CCEL analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $8.50 average of analyst targets
- Upside to target
- +92.3% from the latest close
- Next earnings
- —
- 52-week range
- $2.89 – $4.57
CCEL analyst ratings
1 analystsNumber of analysts at each rating.
CCEL price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CCEL earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Aug '26) | $0.03 | $0.03 | $0.03 | $0.10 | −68.7% | 1 |
| Next quarter (Feb '27) | $0.02 | $0.02 | $0.02 | $0.02 | +5.3% | 1 |
| Current fiscal year (FY2027) | $0.07 | $0.00 | $0.00 | $0.07 | 0.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CCEL revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Aug '26) | $7.5M | $7.5M | $7.5M | −4.8% | 1 |
| Next quarter (Feb '27) | $7.3M | $7.3M | $7.3M | −5.6% | 1 |
| Current fiscal year (FY2027) | $31.5M | $31.5M | $31.5M | −1.5% | 1 |
CCEL EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CCEL revenue: reported and forecast
CCEL EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Aug '26) | −$0.12 | −$0.12 | $0.07 | $0.07 | $0.03 | −125.0% | 1 up · 0 down |
| Next quarter (Feb '27) | $0.00 | $0.00 | $0.00 | $0.00 | $0.02 | — | 0 up · 0 down |
| Current fiscal year (FY2027) | −$0.11 | −$0.11 | −$0.11 | −$0.11 | $0.07 | −163.6% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CCEL earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CCEL beat in 8 of 11.
What analysts expect from CCEL
1 analysts cover Cryo-Cell International; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $8.50, 92.3% above the latest close of $4.42. Analysts expect earnings of $0.07 per share for FY2027, 0.0% from a year earlier. Cryo-Cell International beat the EPS estimate in 8 of the last 11 quarters.
Related: CCEL income statement, CCEL key metrics, CCEL chart. See the CCEL stock overview for the latest quote and news.
CCEL forecast FAQ
What is Cryo-Cell International's price target?
The average analyst price target for Cryo-Cell International is $8.50, 92.3% above the latest close of $4.42.
Is Cryo-Cell International a buy, hold or sell?
Of 1 analysts covering Cryo-Cell International, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Cryo-Cell International's EPS forecast?
Analysts forecast $0.07 per share for FY2027 (range $0.00 to $0.00).
What is Cryo-Cell International's revenue forecast?
The average revenue estimate for FY2027 is $31.5 million, growth of −1.5%.
Does Cryo-Cell International usually beat earnings estimates?
Cryo-Cell International reported EPS at or above the analyst estimate in 8 of the last 11 quarters.